In recent years, the number of class D b-lactamases with carbapenem-hydrolysing properties has increased substantially. Based on amino acid sequence identities, these class D or OXA-type carbapenemases are divided into eight distantly related groups, and they are only remotely related to other class D b-lactamases. A putative ancestor to one of the plasmid-encoded OXA-type carbapenemases has been found.
Introduction
b-Lactam antibiotics, including penicillins, cephalosporins and carbapenems, act cytostatically on bacteria by inactivating peptidoglycan transpeptidases irreversibly. The transpeptidases catalyse the cross-linking of the peptidoglycan polymers in the bacterial cell wall, 1, 2 and inhibition of this polymerization leads to cell death. The transpeptidases are members of the family of penicillin binding proteins (PBPs) from which b-lactamases are likely to have evolved. 3 b-Lactamases are enzymes of entirely bacterial origin that degrade b-lactam antibiotics into antimicrobially inert compounds. The enzymes thus protect the organisms against the lethal actions of b-lactam antibiotics, 4 and the enzymes are the primary cause of bacterial resistance to these drugs. 5 The b-lactamases can be classified into four different molecular groups, A, B, C and D, according to amino acid sequence identities. [6] [7] [8] Class A, C (AmpC) and D b-lactamases use a catalytically active serine residue for inactivation of the b-lactam drug. 9 The enzymes assigned to the molecular class B are metallo-enzymes requiring zinc for their catalytic activity, and they operate through a completely different mechanism. 10, 11 Carbapenems, such as imipenem and meropenem, have a very broad spectrum of activity, and the drugs resist hydrolysis by most of the b-lactamases, including extended-spectrum b-lactamases and derepressed chromosomal AmpC b-lactamases.
12 Most of the metallo-b-lactamases together with some class A and D b-lactamases are able to hydrolyse these compounds. 13, 14 MIC (minimal inhibitory concentration) breakpoints for imipenem and meropenem resistance in non-fastidious Gram-negative pathogens, such as Pseudomonas aeruginosa and Acinetobacter baumannii, and in members of the Enterobacteriaceae have been defined by the NCCLS as ‡16 mg/L. The NCCLS susceptibility breakpoints were established as £4 mg/L. Acquired resistance to carbapenems is mediated by different mechanisms. b-Lactamases, especially the class B enzymes, account for most of the resistance to carbapenems in bacteria. 13, 14 Other resistance mechanisms are attributed to reduced affinity of PBPs for carbapenems, [15] [16] [17] increased efflux of the b-lactam antibiotics, 18, 19 decreased permeability of the outer membrane [20] [21] [22] or to a combination of reduced permeability and high-level production of a b-lactamase, typically an AmpC b-lactamase. [23] [24] [25] [26] The focus of this review is on the class D or OXA-type carbapenemases.
Class D b-lactamases
Historically, the first characterized class D b-lactamases were also referred to as oxacillinases because they commonly hydrolyse the isoxazolylpenicillin oxacillin much faster than classical penicillins, i.e. benzylpenicillin. 27 The designation, OXA, of the class D b-lactamases, thus, refers to their preferred penicillin substrate. 
Subgroups of OXA-type carbapenemases
The carbapenem-hydrolysing OXA enzymes can be subclassified into eight distinct branches or subgroups as shown in Figure 1 . The sequence identities between members of each group are ‡92.5%
whereas the identities between enzymes that belong to different clusters range from 40 to 70%. These eight groups are only remotely related to class D oxacillinases that do not possess carbapenem-hydrolysing properties. In Table 1 , the OXA-type carbapenemases are summarized together with their geographical distribution.
Four of the eight clusters have been identified in A. baumannii, and the isolates were collected in Europe, South America, Asia and French Polynesia ( Table 1 ). The first cluster is formed by OXA-23, 30 also named ARI-1 (an acronym of Acinetobacter resistant to imipenem), together with OXA-27 40 and OXA-49 (AY288523). These enzymes differ by two to five amino acid substitutions.
The second family encompasses the OXA-24, -25, -26, -40 [39] [40] [41] and -72 b-lactamases (AY739646). The sequence divergences between the members of this cluster vary from 1 to 5 amino acids.
The third group consists of the OXA-51 family enzymes, 45, 51, 52 while only a single member, namely OXA-58, 48 represents the fourth group. The recently identified OXA-51 group of b-lactamases comprises a novel phylum among the OXA-type carbapenemases, and the cluster includes also OXA-64 to -66, OXA-68 to -71 and OXA-75 to -78 OXA -23  OXA -27  OXA -49  OXA -64  OXA -71  OXA -51  OXA -78  OXA -66  OXA -76  OXA -65  OXA -69  OXA -68  OXA -77  OXA -70  OXA -75  OXA -24  OXA -40  OXA -26  OXA -72  OXA -25  OXA -58  OXA -48  OXA -SAR2  OXA -54  OXA -55  OXA -SHE  OXA -50b  OXA -50d  OXA -50a  OXA -50e  OXA -60  OXA -60a  OXA -60b OXA -60c OXA -60d Figure 1 . Dendrogram of precursor OXA-type carbapenemases. The tree was constructed by the use of the www-based services, ClustalW algorithm (http://www.genebee.msu.su/clustal) and the Phylogenetic tree printer (http://www.iubio.bio.indiana.edu/treeapp/treeprint-sample2.html). The PoxB enzymes related to the OXA-50 enzymes of P. aeruginosa have been omitted from the dendrogram. References are given in Table 1 . The highly related enzymes, PoxB, have been described in P. aeruginosa from clinical and environmental specimens collected mainly in different European countries. Chromosomally encoded b-lactamases that were at least 98% identical to OXA-55 were found in two other strains of S. algae.
k
The OXA-58 enzyme was identified in several genetically related isolates of A. baumannii.
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OXA-58 enzyme was also plasmid-encoded in the majority of isolates of A. baumannii collected from France, Italy, Spain, Turkey and Romania. 32 An A. junii isolate from Romania also produced a plasmid-encoded OXA-58. The bla OXA-71 gene has also been reported in another A. baumannii isolate from Spain.
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( Figure 1 ). The members of this family diverge by 1-15 amino acid modifications, and the enzymes may be naturally occurring in A. baumannii.
51,52
The fifth group is represented by the chromosomally encoded enzymes OXA-55 47 and OXA-SHE (AY066004) from Shewanella algae. The enzymes deviate by five substitutions.
The plasmid-mediated OXA-48 from Klebsiella pneumoniae 42 groups with the chromosomally mediated OXA-54 from Shewanella oneidensis 46 and form the sixth branch, and the enzymes differ by 20 substitutions.
In a whole genome shotgun (WGS) sequence of Shewanella SAR-2 (CH004480), an environmental microbe collected from the Sargasso Sea, 55 a putative bla OXA and downstream located lysR gene have been identified by an in silico analysis. The OXA-SAR2 enzyme deviates from OXA-48 by a single amino acid substitution located in the N-terminal part of the mature enzyme (residue no. 43 in the precursor sequence according to DBL numbering) implying that OXA-SAR2 may possess carbapenemase activity.
The plasmid-encoded bla OXA-48 and putative lysR genes and their flanking nucleotide sequences from K. pneumoniae 42 were compared with the corresponding sequence from Shewanella SAR-2 (nucleotides 42659-44883 of CH004480). The two sequences are 99.2% identical, owing to 8 transitions, 6 transversions and 4 deletions in the Shewanella sequence. One deletion in the Shewanella sequence had occurred in the region between the bla OXA and lysR genes while the remaining three deletions were located in the 3 0 -end of the lysR gene resulting in truncation of the penultimate amino acid residue of the LysR regulator. This high identity documents that OXA-48 most likely has descended from an OXA b-lactamase of the genus Shewanella.
Genes encoding OXA-type b-lactamases may possibly be normal constituents of the genome of some species of Shewanella. The bla OXA-54 gene has been described in the genome of S. oneidensis, 46,56 while putative bla OXA -type genes have been identified in WGS sequences of Shewanella baltica (AAIO01000124), Shewanella putrefaciens (NZ_AALB01000094), Shewanella sp. ANA-3 (AALH01000006), Shewanella sp. MR-7 (AALI01000021), and Shewanella SAR-1 (CH004559) and SAR-2 (CH004480). Apart from OXA-54, it is not known whether any of these gene products possess carbapenemase activity. Similar genes have not been found in Shewanella frigidimarina (AAIV01000000), Shewanella denitrificans (AAIU01000000) or Shewanella amazonensis (NZ_AAIN00000000).
The seventh and eighth branches are represented by the OXA-50 enzymes in P. aeruginosa 43 and the OXA-60 enzymes in Ralstonia pickettii, 50 respectively, and each group holds several variant enzymes. The members of the OXA-50 cluster differ by 1-5 substitutions, while the OXA-60 variant enzymes deviate from each other by 1-21 amino acid modifications.
The PoxB enzymes identified in various strains of P. aeruginosa 44 are also members of the OXA-50 family as the enzymes differ from the OXA-50s by 1-8 substitutions, corresponding to identities from 99.6 to 97.0%.
However, the PoxB enzyme from P. aeruginosa DSM 1128 44 deviates from this level of identity by having identities of 86. 48 Mobile elements were not linked to the plasmid-borne bla OXA-40 gene (AY228470).
The association of the bla OXA-48 gene with the reversely oriented IS1999 may cause an increased expression of the bla gene, as shown for the bla VEB-1 gene in P. aeruginosa.
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The genetic context of the bla OXA-23 gene characterized by Donald and co-workers 30 was investigated by an in silico analysis of the DNA sequences flanking the gene. The examination showed that the upstream sequence from the bla OXA-23 gene was 99.3% identical to the insertion sequence, ISAba1, described by Segal et al. 60 and Poirel (http://www-is.biotoul.fr; 21 June 2005, date last accessed). This ISAba1 isoform diverged slightly from ISAba1 in the tnp gene and inverted-repeat-left (IR-L), and therefore the variant was designated ISAba1-B. The nucleotide sequence of ISAba1-B contained a deletion and five changes compared with that of ISAba1, and the former occurred in the 5 0 -end of the tnp gene resulting in a premature arrest of translation of the gene. As the orientation of ISAba1-B was reversed compared with the bla OXA-23 gene, IR-L was contiguous to the 5 0 -end of the bla gene. The IR-L of ISAba1-B was also identified in the upstream sequences of other bla OXA-23 genes (AY554200, AY795964, DQ029069) and the bla OXA-27 gene (AF201828). ISAba1 is related to IS4, a heterogeneous family of insertion sequences.
The sequences, including IR-L of ISAba1-B, upstream of the bla OXA-23 (AY554200, AY795964, DQ029069) and bla OXA-27 genes 40 in isolates recovered from Asia were completely identical. In the equivalent sequence from the UK isolate, 30 a heptamer was truncated from the outer boundary to IR-L, but apart from this truncation the remaining sequences in the region between IR-L and the bla locus were identical. The first 75 nucleotides of downstream sequences from the bla OXA-23 and bla OXA-27 genes were completely identical; however, A. baumannii strain 25547/96 (AY795964) contained three transversions in the most distant part (>75 bp) of the downstream sequence. These findings may imply that the genes from Asia and the gene from the UK have been mobilized from the same unknown ancestor.
Most of the OXA-type carbapenemase genes in A. baumannii seem to be chromosomally located (Table 1) , but these genes do not appear to be ubiquitous parts of the genetic background of the species. The G+C contents of the bla OXA-51 family genes vary between 39 and 40%, which is within the range of the G+C contents of A. baumannii genes. 61 As the bla OXA-51 family genes seem to be absent from some A. baumannii strains this may imply that the genes are not omnipresent in the species, but present rather in subpopulations of A. baumannii.
Apart from bla OXA-51 family genes, the G+C contents of the other bla OXA genes in A. baumannii vary between 34 and 38% implying that the latter genes have evolved in other species. Some of these genes have subsequently been embedded in the A. baumannii chromosome. When investigated, the chromosomal OXA-type carbapenemase genes have not been found to be associated with integrons or insertion sequences. 39, 41 Experiments using imipenem for induction of OXA-60 in R. pickettii induced an elevated biosynthesis of the enzyme; 50 whereas the induction of OXA-50 in P. aeruginosa and OXA-69 in A. baumannii failed when challenged with either imipenem or cefoxitin. 43, 52 The investigation by Kong et al. 62 implies why the induction of the OXA-50/PoxB carbapenemase production in P. aeruginosa failed. The synthesis of the OXA-50/PoxB carbapenemase seems to be suppressed by AmpR, 62 the LysR transcriptional activator of the ubiquitous AmpC b-lactamase. 63 In the presence of a b-lactam antibiotic the expression of the OXA-50/PoxB enzyme is more reduced than in the absence of the drug. 62 The AmpR also regulates expression of other genes that are not in the least associated with b-lactam resistance. 62 The ampC genes in A. baumannii and S. oneidensis are not linked to an upstream-located ampR gene. In some A. baumannii strains, the ampC gene seems to be preceded by a transposase gene. The possibility that the production of OXAs of A. baumannii and S. oneidensis may be regulated by other LysRs cannot be entirely excluded. Alternatively, induction may be executed by non-blactam compounds like the induction of other b-lactamases. 64, 65 In S. oneidensis and S. algae, the bla OXA-54 , 46 bla OXA-55 47 and bla OXA-SHE genes (AY066004) are linked to downstream located and divergently transcribed genes encoding putative transcriptional regulators of the LysR-type. However, induction experiments indicating involvement of these transcriptional activators in expression of the bla OXA genes are still lacking. Challenge with cefoxitin and imipenem for induction of the bla OXA-54 gene expression have been performed, but induction failed. 46 It cannot completely be ruled out that the gene products of the lysR genes located downstream from the bla OXA -type genes in S. oneidensis and S. algae may act in a similar manner as AmpR in P. aeruginosa. In A. baumannii and R. pickettii, no regulator gene has been found immediately downstream from the bla OXA gene.
Origin of OXA-type carbapenemases
Environmental microbiota may carry chromosomal genes conferring resistance to antibiotics as a protection against antibioticproducing soil micro-organisms. Imipenem is an N-formimidoyl derivative of thienamycin, which is a natural product of the soil organism Streptomyces cattleya.
66 Possession of carbapenem-hydrolysing enzymes would thus be beneficial for soil bacteria. As a result of this natural selective pressure, the organisms may originally have evolved enzymes with carbapenemase activities or they may have acquired these genes from other bacteria through plasmids acting as vehicles. The genes may either have remained located on plasmids or subsequently become inserted into the chromosome by recombination, co-integration or transposition.
Barlow and Hall 67 have estimated that bla OXA genes have been on plasmids for millions of years, and the ancestors of the mobile OXA-type carbapenemases may thus have disappeared long ago. A more recent mobilization of chromosomal genes to plasmids and interspecies transfer and integration into the chromosome have been described for the ampC genes. [68] [69] [70] The first identified isolate expressing an OXA-type carbapenemase was the OXA-23-producing A. baumannii from Scotland. 29 The isolate was recovered in 1985 before or at the time when imipenem was approved for general use. Likewise, class A b-lactamases with carbapenem-hydrolysing properties were recorded prior to imipenem being licensed for clinical use. Those were IMI-1 and SME-1 which were characterized from isolates collected in 1982 in UK and in 1984 in USA, respectively. 71, 72 These findings strongly suggest that the clinical use of imipenem is not responsible for the evolution of the class A and D carbapenemases; the enzymes were probably present in bacteria long before this.
Biochemical properties of OXA-type carbapenemases
Mature OXA-type carbapenemases contain between 243 and 260 amino acid residues with experimentally determined molecular masses that vary from 23 to 35.5 kDa. The OXA-69 enzyme is the first OXA-type carbapenemase that has been shown to form a dimer, 52 similar to many class D oxacillinases. The isoelectric points (pIs) of the enzymes vary between 5.1 and 9.0 ( Table 1) .
The active-site serine b-lactamases operate by a simple threestep model involving acylation and deacylation, which is schematically represented by
In the first step, the b-lactamase (E) and substrate (S) interact into a Henri-Michaëlis complex (ES) which may either dissociate or form a transient acyl-enzyme intermediate (E-S*). The intermediate is formed as a result of a nucleophilic attack on the carbonyl carbon atom of the b-lactam ring by the g-O of Ser 70 , and the intermediate is subsequently rapidly deacylated releasing a ringopened product (P) and the intact enzyme.
The three-step acylation-deacylation mechanism is identical to the serine-active b-lactamases, but the catalytic pathways of class D b-lactamases differ from those operating in class A and from AmpC b-lactamases. 73 In Eqn. 1, k +1 , k -1 , k +2 , k -2 and k +3 are microscopic rate constants. Both acylation, represented by k +2 , and deacylation (k +3 ) are usually rapid steps resulting in high turnover numbers [k cat = (k +2 ·k +3 )/(k +2 +k +3 )] and catalytic efficiencies [k cat /K m = (k +1 ·k +2 )/ (k +1 +k +2 )]. 74 The acylation rate (formation of the acyl-enzyme intermediate) is represented by k cat /K m whereas the turnover number, k cat , corresponds to the deacylation rate. 74 The steady-state kinetic constants, k cat and K m , have been determined for a number of purified OXA-type carbapenemases (Table 2) . Very low values of both k cat and K m can result in a high k cat /K m value (apparent high catalytic efficiency), but in conjunction k cat and k cat /K m reflect the genuine catalytic efficiency of a b-lactamase against a b-lactam antibiotic. 74 Even with an extremely low value of k cat for hydrolysis of a b-lactam, the agent may still be hydrolysed efficiently in vivo, because the organism may produce exceptionally large periplasmic concentrations (up to 1 mM) of the b-lactamase. 75 As the maximal velocity attainable for the b-lactam degradation (V max ) is equal to the product of k cat and the enzyme concentration [E] 0 (V max = k cat ·[E] 0 ), 75 the low k cat value may be counterbalanced by a high [E] 0 . If a specific porin deficiency besides restricts the penetration of the antibiotic into the bacteria, a large fraction of the entering b-lactam can be degraded which may result in resistance to that antibiotic.
Phenotypically, many class D b-lactamases belong to the Bush subgroup 2d b-lactamases which are defined as enzymes hydrolysing oxacillin at a rate >50% of that for benzylpenicillin. 27 However, most of the OXA-type carbapenemases hydrolyse oxacillin at a much lower rate. Only OXA-25, OXA-26, OXA-55 40,47 and the enzymes described by Hornstein et al. 53 and Afzal-Shah et al.
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hydrolyse oxacillin at rates >50% than that for benzylpenicillin and thus comply fully with the definition of the subgroup 2d b-lactamases. The substrate specificities of the OXA-type carbapenemases are diverse, but generally the enzymes hydrolyse penicillins (benzylpenicillin, ampicillin, piperacillin and ticarcillin) and the narrow-spectrum cephalosporins, cefalotin and cefaloridine efficiently, while the extended-spectrum b-lactams, ceftazidime, cefotaxime and aztreonam, are not or only very poorly hydrolysed ( Table 2) .
Most of the OXA-type carbapenemases have low hydrolytic activities against imipenem and especially against meropenem. Except for OXA-69 52 and the pI 6.9 enzyme from A. baumannii,
all OXA-type carbapenemases show higher affinity (lowest K m ) for imipenem than for any other tested b-lactam antibiotic. Most of the OXA-type carbapenemases exert their hydrolysis of imipenem by a combination of a low turnover number and high affinity for the drug. Meropenem is consistently hydrolysed at a much lower rate than imipenem, but not by the OXA-type enzyme characterized by Hornstein and co-workers. 53 OXA-48, OXA-54 and the unsequenced OXA-type carbapenemase described by Hornstein et al. 53 however, hydrolyse, Review imipenem at levels significantly higher than those of the other OXA-type carbapenemases ( Table 2 ). The kinetic parameters of these three enzymes for imipenem are similar to those of the zincdependent carbapenemases, L1e, VIM-1 and JOHN-1.
76-78
Generally, class D b-lactamases are inhibited less efficiently by clavulanate than the majority of the other group 2 b-lactamases to which the class D enzymes belong. In keeping with this inhibition profile, all OXA-type carbapenemases are inhibited more efficiently by tazobactam than by clavulanate.
A classical feature of most class D b-lactamases is the inhibition by NaCl, which is attributed to the presence of a Tyr residue in the Tyr 144 -Gly-Asn motif. 41 OXA b-lactamases having a Phe-Gly-Asn element instead (OXA-23, OXA-25, OXA-26, OXA-27, OXA-40, OXA-49 and OXA-72) are not or only weakly inhibited by NaCl. Surprisingly, OXA-24 holding the triad Phe-Gly-Asn is inhibited by NaCl. 39 Table 3 illustrates the in vitro susceptibilities of Escherichia coli transconjugants or transformants that carry recombinant plasmids encoding an OXA-type carbapenemase.
Susceptibility patterns
In the E. coli derivatives, OXA-type carbapenemases confer high-level resistance to aminopenicillins (ampicillin or amoxicillin) and carboxypenicillins (ticarcillin). The susceptibilities to ureidopenicillins (piperacillin) are diverse as only OXA-40 and OXA-48 provide resistance to the drugs. The susceptibilities of the E. coli derivatives to cephalosporins, including narrowspectrum cephalosporins (cefalotin and cefuroxime), the oxyimino-cephalosporins (ceftazidime and cefotaxime) and the 7-a-methoxy-cephalosporins (cefoxitin), oxacephems (moxalactam) and monobactams (aztreonam) are more or less unchanged compared with the reference strains. Only OXA-48 provides resistance to cefalotin.
The effects of the inhibitors, clavulanate and tazobactam, on the susceptibility of the E. coli transconjugants or transformants are also compiled in Table 3 . These E. coli strains are not susceptible to the action of the inhibitors, as the penicillin resistance is unchanged after addition of an inhibitor, with the exception of OXA-23 that shows an 8-fold reduction in MIC of piperacillin in the presence of tazobactam.
The OXA-48-producing K. pneumoniae isolate shows a highlevel resistance to carbapenems (MIC = 64 mg/L). 42 This may be the result of a combined action of a high production of OXA-48, owing to the association of the bla OXA-48 gene with IS1999 59 and the lack of a 36 kDa porin. 42 The low level of resistance (MIC £ 8 mg/L) to imipenem and meropenem conferred by the naturally produced OXA-type carbapenemases in P. aeruginosa, 43 A. baumannii 45 and R. pickettii 50 may depend on a combination of low activity of the enzymes against carbapenems and the amount of enzyme produced. The nosocomial isolates of A. baumannii producing carbapenemases, apart from OXA-51, show high-level resistance to imipenem and meropenem (MIC >> 8 mg/L), 29, 33, 35, [38] [39] [40] [41] 48, 49, 53 but the OXA-type carbapenemases in the E. coli derivatives provide only reduced susceptibility to the carbapenems (MIC £ 2 mg/L) ( Table 3 ). This may indicate that additional resistance factors in the nosocomial isolates co-operate to enhance the resistance to carbapenems.
Alterations in the access of antibiotics to the organisms may contribute to a high level of resistance to the carbapenems. In an A. baumannii isolate carrying OXA-24, the reduced expression of two outer membrane porins (OMPs) may restrict the membrane permeability and add to the high MICs to imipenem and meropenem (128 and 256 mg/L, respectively). 79 The high level of carbapenem resistance (MICs ‡ 32 mg/L ) of the A. baumannii isolates producing OXA-23 and OXA-58 may be caused by elevated expression of both the OXA-type carbapenemase and an efflux Review pump. 80 The linkage of the bla OXA-23 and bla OXA-58 genes to the insertion sequences ISAbA1 and ISAbA3, respectively, may lead to an increased production of the enzymes probably because the ISs may supply the genes with strong promoter sequences. 80 In A. baumannii, a combined action of the AmpC b-lactamase with weak carbapenemase activity and reduced expression of OMPs may also result in resistance to carbapenems. 81 Other mechanisms involve diminished production of PBPs, reduced affinity of PBPs for carbapenems 82, 83 or loss of OMPs. 21, [84] [85] [86] Most of the nosocomial isolates of A. baumannii producing OXA-type carbapenemases exhibit high MICs to oxyimino-cephalosporins and to the 7-a-methoxy-cephalosporin cefoxitin, 39 ,40,53,54 which may be caused by hyperproduction of the ubiquitous AmpC b-lactamase. 87 Other b-lactamases have also been recorded in OXA-type carbapenemase-producing isolates, and those are TEM-1-like enzymes, 38,39,42,54 SHV-2a, 42 OXA-22 50 and OXA-47 42 together with some unidentified b-lactamases. 40, 54 These enzymes possess no detectable activity against carbapenems, but they may contribute to the overall b-lactam resistance profile of the isolates.
Many of the A. baumannii clinical strains were also resistant to several conventional non-b-lactam antibiotics, such as aminoglycosides, fluoroquinolones, sulphonamides, chloramphenicol and tetracycline.
Structure-function relationships
The crystal structures of the prototypic class D b-lactamases, OXA-1, OXA-2 (Protein Data Bank, http://www.rcsb.org/pdb, Entry 1K38) and OXA-10 have been determined. 73, 88 Despite large evolutionary distances between the three enzymes (identities between 23.3 and 33.7%), the overall three-dimensional structures are very similar. 88 Thus, it may be hypothesized that the structures of the OXA-type carbapenemases may be very similar to the structures of the class D oxacillinases.
The crystal structure of the OXA-13 oxacillinase complexed with meropenem has been reported. 89 Binding of meropenem to the apoenzyme leads to displacement of residues and loops, especially the catalytically essential Ser 118 . The OXA-13:meropenem complex is not hydrolysed because the distance between the catalytic water molecule and the acyl carbonyl of meropenem is too great. 89 At present, it is not known which amino acid residues play an essential role for the carbapenemase activity in the OXA-type carbapenemases as comprehensive investigations involving sitedirected mutagenesis have not been published. Multiple sequence alignment of the class D b-lactamases has revealed that a residue common to all OXA-type carbapenemases was also present in the same position in at least some of the class D oxacillinases that do not show carbapenemase activity and vice versa. Consequently, it appears that no specific residue(s) is solely responsible for the carbapenemase activity of the OXA-type carbapenemases. Rather, it is more likely that specific residues in enzymes may interact in a way to cause a specific local conformation of the active site leading to a proper positioning of the catalytic water molecule and consequently to hydrolysis of the carbapenem:OXA complex.
Conclusion
This review underlines that the OXA-type carbapenemases are increasingly reported worldwide. The vast majority of OXA-type carbapenemases has so far been found in nonenterobacterial species, especially A. baumannii. The OXA-type carbapenemases, OXA-50, OXA-51 and OXA-60, seem to be naturally occurring enzymes in the species P. aeruginosa, A. baumannii and R. pickettii, respectively.
Most of the OXA-type carbapenemases confer only reduced susceptibility to the carbapenems, but unless secondary resistance mechanisms, such as altered permeability, reduced affinity of PBPs for carbapenems or increased efflux, are involved the clinical detection of organisms producing these enzymes remains difficult.
It has been experimentally shown that an organism producing an enzyme with very low activity against a substrate may evolve enzymes that are much more efficient when the organism is exposed to the substrate. 90 This aspect has clearly been illustrated by the SHV b-lactamases which have evolved from broadspectrum b-lactamases to extended-spectrum, inhibitor-resistant or carbapenem-hydrolysing enzymes. AmpC b-lactamases with weak carbapenemase activity have been described in both A. baumannii and P. aeruginosa. Thus, it may be anticipated that the clinical use of carbapenems may lead to the emergence of P. aeruginosa and A. baumannii producing more efficient mutant enzymes. This prospect is worrisome as A. baumannii and P. aeruginosa account for many severe nosocomial infections.
The chromosomal location of many of the OXA-type carbapenemase encoding genes has certainly contributed to the slow spread of these genes. By inappropriate use of carbapenems the plasmid-encoded genes will likely spread, owing to the increased selective pressure.
The ancestors of most of the mobile carbapenem-hydrolysing OXA b-lactamases are unknown.
